Overview

Pancreatic cancer is challenging to treat, often diagnosed at an advanced stage and resistant to conventional therapies. Recent advancements in medical science reveal innovative therapies for improved outcomes and extended life. Developments in immunotherapy, targeted drug delivery, personalized medicine, and gene editing reshape how clinicians approach this disease. From immune checkpoint inhibitors to cancer vaccines and CRISPR-based strategies, these new treatments are designed to overcome the biological barriers of pancreatic tumors. As research evolves, innovative therapies enhance global understanding of pancreatic cancer and patient treatment. Innovative Therapies for Pancreatic Cancer examines the latest advances in treating pancreatic cancer, covering immunotherapy, targeted therapies, gene editing, nanotechnology, and precision medicine. It addresses the clinical, ethical, and personal dimensions of these innovative approaches, providing a well-rounded perspective on the progress and challenges in the field. This book covers topics such as genetics, drug development, and oncology, and is a useful resource for medical and healthcare professionals, oncologists, academicians, researchers, and scientists.

Full Product Details

9798337314709

Table of Contents

Reviews

Author Information

Dr. Pallavi Singh has been a Seasoned academician and versatile Researcher with more than 17 years of experience in teaching, research, Innovation, and leadership experience in the domain of Biotechnology. She holds B.Tech, M.Tech and Ph.D degree in Biotechnology. She is currently serving as Professor and Program Coordinator (B.Tech. Biotechnology) in Department of Biotechnology at Graphic Era Deemed to be University, Uttarakhand, India. She has published over 57 research papers in reputed National and International journals which includes journals like International Journal of Surgery, Frontiers in Microbiology, Current Issues in Molecular Biology, Computational Toxicology, Journal of Nanomaterials Scientific Reports, Plant Science Today etc. She has further published 2 Books, 5 Book chapters along with many International and National conference presentations. Further, She has published 9 patents in the domain of computational biology, Cancer and Bioprocess Engineering. 4 of her patents have been granted in years 2023 and 2024. She has h index of 11 and i10 index of 11 and is in Editorial Board of many Scopus and SCI journals. She has guided 35 projects at B.Tech and M.Tech level and 5 students are currently pursuing their Ph.D under her guidance. Shiva Prasad Kollur is working as Associate Professor in Chemistry at Amrita Vishwa Vidyapeetham, Mysuru Campus, India. His research interests included Anticancer therapeutics, Bioinorganic and Materials Chemistry. He has published over 250 scientific research articles in international peer-reviewed journals and several of his research findings are patented. He has mentored more than 40 scholars (Grads/Postgrads) for their degree fulfilment and 8 PhD scholars are presently working under his supervision. Dr. Raghavendra G. Amachawadi is currently working as an Associate Professor in Department of Clinical Sciences, Kansas State University, Manhattan. He has published 116 research articles and has h index of 28 and i10 index of 65. He has handled National level projects in United states and has obtained total funding of dollars14,244,503 from prominent agencies in United states like USDA-NIFA, USAID-Global Food Systems, FDA, National Pork Board, Elanco Animal Health, National Cattlemen’s Beef Association (Beef check-off), ICASA-FFAR, and Animal Health Commodity groups.He has expertise in microbiome, metagenomics, and metabolomics research, and investigates the complex interactions between host, microbial communities, and pathogens, aiming to develop innovative, antibiotic-free intervention strategies to control critical issues such as liver abscesses in feedlot cattle, bovine respiratory disease, and swine colibacillosis. He has thorough expertise in animal research and translational medicine.

Tab Content 6

Countries Available